Next |
home / stock / lgvn / lgvn message board
Subject | By | Source | When |
---|---|---|---|
institutions loading up,nhod,ka-freaking-BOOM!!! | 81vette | investorshub | 05/09/2023 4:29:36 PM |
ZERO BORROW,just now out of shares,1st time in | 81vette | investorshub | 05/09/2023 4:06:18 PM |
5m float,short 166k shares,197Xs ave volume should push | 81vette | investorshub | 05/09/2023 2:45:28 PM |
MomentumIts now last up | Roadtojourney | investorshub | 05/08/2023 8:13:19 PM |
$LGVN Price gaining last trade up | subslover | investorshub | 05/08/2023 4:36:46 PM |
Price now up | heyitsmeagain | investorshub | 05/07/2023 7:18:22 PM |
$LGVN Price gaining | heyitsmeagain | investorshub | 05/06/2023 4:26:10 PM |
Price trading | goingUPagain | investorshub | 05/01/2023 10:33:37 PM |
$LGVN The trading up | pinkslipjunkie | investorshub | 05/01/2023 3:10:31 PM |
MomentumIts trading last up | TheFinalCD | investorshub | 04/27/2023 6:09:37 PM |
$LGVN MomentumIts trading up | bobbyinredwood | investorshub | 04/26/2023 8:28:29 AM |
Lets go go go go... Up up and away we go. | Anite | investorshub | 04/25/2023 8:25:06 PM |
$LGVN is it bear time? Or do we go bull? | dennisv | investorshub | 04/23/2023 10:17:14 PM |
$LGVN MomentumIts gaining last up | Sibware | investorshub | 04/21/2023 5:34:23 PM |
$LGVN bears and bulls | help me | investorshub | 04/20/2023 4:56:17 PM |
$LGVN Good read | dennisv | investorshub | 04/20/2023 4:52:46 AM |
$LGVN The now | Nealmi1971 | investorshub | 04/19/2023 3:30:04 AM |
and the shorts continue | vhgier | investorshub | 04/18/2023 6:29:21 PM |
got some short data | Roadtojourney | investorshub | 04/17/2023 6:37:26 PM |
$LGVN just the news we needed | TheFinalCD | investorshub | 04/17/2023 2:18:21 PM |
News, Short Squeeze, Breakout and More Instantly...
Longeveron Inc. Company Name:
LGVN Stock Symbol:
NASDAQ Market:
Phase 2b clinical trial evaluating Lomecel-B TM in rare pediatric disease HLHS on track for completing enrollment by end of 2024 Data from Phase 2a clinical trial evaluating Lomecel-B TM in Alzheimer’s Disease selected for Featured Research Oral Presentation at 2024 Alzheimer...
Longeveron (NASDAQ: LGVN) , a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, is reporting changes on its board of directors. The following transitions on the board have been announced: Richard Kender, retired SVP of bu...
Richard Kender, retired SVP of Business Development and Corporate Licensing for Merck & Co., Inc., has been appointed to the Longeveron Board...